, US National Institutes of Health. National Institute of Allergy and Infectious Diseases. Herd effect, 2015.
An Introduction to Infectious Disease Modelling, p.369, 2010. ,
Jenner and the history of smallpox and vaccination, BUMC PROCEEDINGS, vol.18, pp.21-25, 2005. ,
Bridging the knowledge gaps in vaccine design, Nature Biotechnology, vol.25, issue.12, pp.1361-1367, 2007. ,
History of vaccination, Proc Natl Acad Sci, vol.111, issue.34, pp.12283-12290, 2014. ,
Department of Health & Human Services. Types of Vaccines, 2012. ,
Vaccine discovery and translation of new vaccine technology, Lancet, vol.378, pp.360-68, 2011. ,
Vaccines: the fourth century, Clin Vaccine Immunol, vol.16, issue.12, pp.1709-1728, 2009. ,
The contribution of vaccination to global health: past, present and future, Phil. Trans. R. Soc. B, vol.369, 2014. ,
, , 2016.
The Red Book through the Ages, Pediatrics, vol.132, issue.5, 2013. ,
Statistical Abstract of the United States. 20th Century Statistics, 1999. ,
The future of immunization policy, implementation, and financing, Lancet, vol.378, pp.439-487, 2011. ,
Gavi's mission, 2017. ,
GAVI helps DTP3 coverage rise after stagnation, 2017. ,
The Value of Vaccines in Disease Prevention, 2014. ,
Contagious Disease in the United States from 1888 to the Present, N Engl J Med, vol.369, issue.22, pp.2152-2160, 2013. ,
The global value of vaccination, Vaccine, vol.21, issue.7-8, pp.596-600, 2003. ,
State of the world's vaccines and immunization, 3 rd edition. Geneva, World Health Organization, 2009. 21. WHO. World Immunization Week, 2013. ,
Economic Evaluation of the Routine Childhood Immunization Program in the United States, Pediatrics, vol.133, issue.4, 2009. ,
, Vaccines Work: Key Facts and Figures, 2010.
The vaccine paradox, Lancet, vol.378, issue.9788, pp.296-304, 2011. ,
WHO and UNICEF estimates of national infant immunization coverage: methods and processes, Bull World Health Organ, vol.87, pp.535-541, 2009. ,
, Vaccines and Biologicals-data, statistics and graphs, 2016.
Accessed online at <http://www.gavi.org/support/apply/countries-eligible-for-support> 30. WHO. Global Vaccine Action Plan, 2011. ,
, Global routine vaccination coverage, 2015.
Age of pharmaceutical industry, 1999. ,
The worldwide vaccine market: what are the main challenges with a full conversion toward pre-filled syringes? Professional Thesis, ESSEC Business School, p.63, 2009. ,
Vaccine production, distribution, access, and uptake, Lancet, vol.378, pp.428-466, 2011. ,
, Xerfi Global. Pharmaceutical Groups-World, 2016.
, Mordor Intelligence. Preventive Vaccines Market-Trends and Forecasts, pp.2017-2022, 2017.
, , p.2022, 2017.
The next decade of vaccines: societal and scientific challenges, Lancet, vol.378, pp.348-59, 2011. ,
Vaccine Market-Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014. ,
, , 2016.
, , 2016.
, , 2016.
Addressing the vaccine confidence gap, Lancet, vol.378, issue.9790, pp.526-561, 2011. ,
Understanding those who do not understand: a brief review of the antivaccine movement, Vaccine, vol.19, pp.2440-2445, 2001. ,
Vaccine hesitancy: Definition, scope and determinants, Vaccine, vol.33, issue.34, pp.4161-4165, 2015. ,
Applying Behavioral Economics to Public Health Policy, Am J Prev Med, vol.50, issue.5, pp.13-19, 2016. ,
Vaccine risks: real, perceived and unknown, Vaccine, vol.17, issue.3, pp.41-47, 1999. ,
Thinking, Fast and Slow, 2011. ,
Applying lessons from behavioral economics to increase flu vaccination rates, Health Promot Int, p.31, 2016. ,
Public Law and Legal Theory Working Papers, 2007. ,
Attitude to vaccination: a critical review, Soc Sci Med, vol.112, pp.1-11, 2014. ,
Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program, Vaccine, vol.23, issue.24, pp.3103-3110, 2005. ,
Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents, BMC Public Health, vol.12, p.498, 2012. ,
The Determinants of Trust and Credibility in Environmental Risk Communication: An Empirical Study, Risk Anal, vol.17, issue.1, pp.43-54, 1997. ,
Anti-vaccination movements and their interpretations, Soc Sci Med, vol.62, issue.3, pp.628-670, 2006. ,
Vaccine hesitancy and healthcare providers, Vaccine, vol.34, issue.52, pp.6700-6706, 2016. ,
Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population, J Clin Rheumatol, vol.18, issue.5, pp.237-278, 2012. ,
Vaccine hesitancy among healthcare workers in Europe: A qualitative study, Vaccine, vol.34, issue.41, pp.5013-5020, 2016. ,
Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France, EBioMedicine, vol.2, issue.8, pp.891-898, 2015.,
URL : https://hal.archives-ouvertes.fr/hal-01816807
, Association E3M. For aluminium-free vaccines, 2017.
Accessed online at <http://www.iccr.org/> 65. The Economist. Vaccines, A smarter jab, 2010. ,
, Vaccines Are Profitable, So What?, 2015.
Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices, Vaccine, vol.33, issue.34, pp.4204-4215, 2015. ,
What every CEO needs to know about nonmarket strategy. MIT Sloan Management Review, 2010. ,
Beyond corporate social responsibility: Integrated external engagement, 2013. ,
Understanding and Advancing the Concept of, Nonmarket'. Business & Society, vol.42, issue.3, pp.297-327, 2003.,
DOI : 10.1177/0007650303257504
Tackling sociopolitical issues in hard times: McKinsey Global Survey results, 2009. ,
Pharmaceutical Companies' Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination, Am J Public Health, vol.102, issue.5, pp.893-898, 2012. ,
Welcomes GSK's Decision to Lower Price of Pneumonia Vaccine for Some of the World's Most Vulnerable Children, 2016. ,
welcomes Pfizer's pneumonia vaccine price reduction for children in humanitarian emergencies, 2016. ,